These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1276796)

  • 21. [Preliminary results and considerations of the use of amphotericin B in topical therapy of mycotic vulvovaginitis].
    Bortolozzi G
    Ann Ostet Ginecol Med Perinat; 1970 Mar; 92(3):192-204. PubMed ID: 5535562
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence and management of non-albicans vaginal candidiasis.
    Hettiarachchi N; Ashbee HR; Wilson JD
    Sex Transm Infect; 2010 Apr; 86(2):99-100. PubMed ID: 20332368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Squibb's amphotericin B in treatment of Candida albicans and Trichomonas vaginalis infections].
    Panaitescu D; Perju A; Balotă V
    Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):79-86. PubMed ID: 5096863
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of refractory Candida krusei vaginitis with topical amphotericin B.
    Chamorro-de-Vega E; Gil-Navarro MV; Perez-Blanco JL
    Med Clin (Barc); 2016 Dec; 147(12):565-566. PubMed ID: 27567339
    [No Abstract]   [Full Text] [Related]  

  • 25. Guideline vulvovaginal candidosis (2010) of the German Society for Gynecology and Obstetrics, the Working Group for Infections and Infectimmunology in Gynecology and Obstetrics, the German Society of Dermatology, the Board of German Dermatologists and the German Speaking Mycological Society.
    Mendling W; Brasch J; ; ; ;
    Mycoses; 2012 Jul; 55 Suppl 3():1-13. PubMed ID: 22519657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Walsh TJ; Denning DW; Drusano GL
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3760-2. PubMed ID: 17682101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptococcal meningitis complicating systemic lupus erythematosus: two patients treated with flucytosine and amphotericin B.
    Speller DC; Fakunle F; Cairns SA; Stephens M
    J Clin Pathol; 1977 Mar; 30(3):254-61. PubMed ID: 845273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter: Another case of disseminated candidiasis.
    Di Liberti JH; Hughes RA
    Pediatrics; 1975 Jun; 55(6):897-8. PubMed ID: 1134896
    [No Abstract]   [Full Text] [Related]  

  • 29. [Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
    Fortun Abete J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():4-14. PubMed ID: 9441305
    [No Abstract]   [Full Text] [Related]  

  • 30. A new treatment for monilial vaginitis.
    Practitioner; 1971 Aug; 207(238):236-8. PubMed ID: 4935661
    [No Abstract]   [Full Text] [Related]  

  • 31. Recent developments in the therapy of chromoblastomycosis.
    Ferreira Lopes C
    Bull Pan Am Health Organ; 1981; 15(1):58-64. PubMed ID: 7248640
    [No Abstract]   [Full Text] [Related]  

  • 32. [Findings and observations on the incidence and pathology of vaginal mycoses in pregnancy].
    Perretti F
    Minerva Ginecol; 1975 Apr; 27(4):284-90. PubMed ID: 1134677
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of systemic mycoses. Panel discussion.
    Scand J Infect Dis Suppl; 1978; (16):87-92. PubMed ID: 285462
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of opportunistic systemic mycoses.
    Norrby R; Eilard T
    Scand J Infect Dis Suppl; 1978; (16):59-64. PubMed ID: 373079
    [No Abstract]   [Full Text] [Related]  

  • 35. [Early results of the use of amphotericin B in vulvovaginal moniliasis].
    Monti R
    Minerva Ginecol; 1969 Apr; 21(7):410-1. PubMed ID: 5404898
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
    Czaika V; Tietz HJ; Schmalreck A; Sterry W; Schultze W
    Mycoses; 2000; 43 Suppl 2():45-50. PubMed ID: 11291577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.
    Halkin H; Ravid M; Zulman J; Reichert N
    Isr J Med Sci; 1974 Sep; 10(9):1148-52. PubMed ID: 4611967
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of systemic candidiasis].
    Cascioli CF; Balletta M; Donadio P; Liguori M
    Minerva Med; 1990 Jun; 81(6):481-3. PubMed ID: 2359504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combination of antifungal chemotherapeutic agents in experimental candidiasis in mice].
    Bassetti D; Fabbri A; Navone C; Ciravegna B
    Ann Sclavo; 1977; 19(5):1043-8. PubMed ID: 616259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Candida mycoses of mucous membranes].
    Grimmer H
    Arch Dermatol Forsch; 1972; 244():398-400. PubMed ID: 4539716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.